A REAL-WORLD DATABASE ANALYSIS OF HEMODIALYSIS PATIENTS PRESCRIBED A CHANGE IN PHOSPHATE BINDER THERAPY FROM CALCIUM ACETATE TO SUCROFERRIC OXYHYDROXIDE

被引：0
|
作者：
Rastogi, Anjay [1 ]
Parameswaran, Vidhya [2 ]
Ficociello, Linda [2 ]
Mullon, Claudy [2 ]
Kossmann, Robert [3 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Fresenius Med Care Renal Therapies Grp, Waltham, MA USA
[3] Fresenius Med Care North Amer, Waltham, MA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2020年 / 75卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
300
引用
收藏
页码：623 / 623
页数：1
相关论文
共 50 条
  • [41] Real-World Phosphate Binder Use Among Dialysis-Dependent Patients With CKD
    Berner, Todd
    Ferro, Christine
    Dieguez, Gabriela
    Metz, Steve
    Moore, Jennifer
    Szabo, Erika
    Kovesdy, Csaba P.
    NEPHRON, 2023, 147 (10) : 583 - 590
  • [42] CALCIUM ACETATE FOR PHOSPHATE-BINDING IN HEMODIALYSIS-PATIENTS WITH HYPERPHOSPHATEMIA RESISTANT TO THERAPY
    DECHENE, M
    HECKING, E
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1994, 23 (07) : 320 - 325
  • [43] A Real-World Experience of Desidustat in Maintenance Hemodialysis Patients-A 1-Year Retrospective Database Analysis From a Single Center Desidustat-A Real World Experience in Hemodialysis Patients From a Single Center
    Jeloka, Tarun
    Sanwaria, Priyanka
    Khiste, Saurabh
    SEMINARS IN DIALYSIS, 2025,
  • [44] CHANGES IN MINERAL BONE DISORDER BIOMARKERS AND PHOSPHATE BINDER (PB) PILLS/DAY IN HEMODIALYSIS (HD) PATIENTS SWITCHING FROM FERRIC CITRATE (FC) TO SUCROFERRIC OXYHYDROXIDE (SO): A ONE-YEAR FOLLOW UP ANALYSIS
    Zhou, Meijiao
    Ficociello, Linda
    Mullon, Claudy
    Anger, Michael
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S29 - S29
  • [45] A Real-world Cost-effectiveness Analysis of Sevelamer Versus Calcium Acetate in Korean Dialysis Patients
    Cho, Jang-Hee
    Jang, Hye Min
    Jung, Hee-Yeon
    Choi, Ji-Young
    Park, Sun-Hee
    Kim, Chan-Duck
    Yang, Chul Woo
    Jin, Dong-Chan
    Kim, Yong-Lim
    CLINICAL THERAPEUTICS, 2018, 40 (01) : 123 - 134
  • [46] EFFICACY AND SAFETY OF INTRAVENOUS PARICALCITOL TREATMENT IN CHINESE HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM: A REAL-WORLD DATABASE ANALYSIS
    Wang, Niansong
    Jiang, Gengru
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1745 - 1745
  • [47] A Real-World Experience of Desidustat in Maintenance Hemodialysis Patients-A 1-Year Retrospective Database Analysis From a Single Center
    Jeloka, Tarun
    Sanwaria, Priyanka
    Khiste, Saurabh
    SEMINARS IN DIALYSIS, 2025, 38 (02) : 139 - 145
  • [48] Real-World Safety of Prostate Cancer Focal Therapy: MAUDE Database Analysis
    Qian, Zhiyu
    Xiao, Boyuan
    Dagnino, Filippo
    Feldman, Julia
    Song, Jonathan
    Zurl, Hanna
    Stelzl, Daniel
    Korn, Stephan
    Reis, Leonardo
    Moore, Caroline M.
    Trinh, Quoc-Dien
    Cole, Alexander P.
    JOURNAL OF ENDOUROLOGY, 2024,
  • [49] WEIGHT CHANGE IN SCHIZOPHRENIC PATIENTS PRESCRIBED WITH ANTIPSYCHOTICS IN UNITED STATES: A REAL-WORLD EVIDENCE STUDY
    Pochiero, I
    Calisti, F.
    Comandini, A.
    Del Vecchio, A.
    Costamagna, I
    Rosignoli, M. T.
    Heiman, F.
    Peduto, I
    Cattaneo, A.
    VALUE IN HEALTH, 2020, 23 : S584 - S585
  • [50] AN ECONOMIC ANALYSIS OF POTENTIAL COST SAVINGS ASSOCIATED WITH SWITCHING FROM SEVELAMER TO SUCROFERRIC OXYHYDROXIDE FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN HEMODIALYSIS PATIENTS IN A US SETTING
    Rosen, Melissa M.
    Ficociello, Linda H.
    Parameswaran, Vidhya
    Mullon, Claudy
    Kossmann, Robert J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (04) : 580 - 580
12345